首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.
【24h】

Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.

机译:抗凝血酶和水rud素的失活受损,并与来自抗磷脂综合症患者的抗凝血酶抗体形成复合物,保持了凝血酶的纤维蛋白原凝结活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Immunoglobulin G (IgG) isolated from the blood plasma of a patient with secondary antiphospholipid syndrome (APS) expresses fibrinogen-clotting and amidolytic activity (the thrombin activity in 20 micromole IgG is equivalent to approximately 5 nmole pure thrombin), and activates factor XIII. Hirudin (1 microM) decreases the intrinsic thrombin activity of the APS IgG by only 25%, whereas it inhibits completely pure thrombin with equivalent activity. Under conditions, when antithrombin inactivates 60% of the thrombin activity in the presence of normal IgG, the APS IgG protects almost completely the added thrombin against inactivation by antithrombin. Heparin, however, partially relieves this protective effect and at the same time it facilitates the inhibition of the intrinsic thrombin activity by antithrombin. The APS IgG reduces the thrombin activity in protein C activation assay by 50% compared to the activity in the presence of normal IgG. All described properties are related to the Fab fragment of the antibody. The IgG preserving the fibrin-generating activity of thrombin with concomitant protection against inhibitors unravels a new aspect of the thrombotic mechanism in APS. This condition is probably rare: only one out of 23 examined patients with primary or secondary APS expresses IgG with the described properties.
机译:从患有继发性抗磷脂综合症(APS)的患者的血浆中分离出的免疫球蛋白G(IgG)表现出纤维蛋白原凝结和酰胺分解活性(20微摩尔IgG中的凝血酶活性相当于大约5纳摩尔纯凝血酶),并激活XIII因子。水rud素(1 microM)仅将APS IgG的固有凝血酶活性降低25%,而它抑制具有同等活性的完全纯的凝血酶。在一定条件下,当在正常IgG存在下抗凝血酶使60%的凝血酶活性失活时,APS IgG几乎完全保护了添加的凝血酶免受抗凝血酶的灭活。然而,肝素部分地减轻了这种保护作用,同时它促进了抗凝血酶对固有凝血酶活性的抑制。与正常IgG存在下的活性相比,APS IgG在蛋白C活化分析中将凝血酶活性降低了50%。所有描述的特性均与抗体的Fab片段有关。保留凝血酶的纤维蛋白生成活性并同时具有针对抑制剂的保护作用的IgG揭示了APS血栓形成机制的新方面。这种情况可能很罕见:在接受检查的23名原发性或继发性APS患者中,只有1名表达具有上述特性的IgG。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号